News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioClinica, Inc. European User Conference Reflects Expansion Trend In Europe



3/5/2014 9:58:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEWTOWN, PA, March 5, 2014 – BioClinica®, Inc., a leading provider of specialized outsourced clinical trial management solutions, today announced that its European User Conference held in Cologne, Germany was a tremendous success and exceeded expectations, further solidifying its expansion in Europe. The Company announced earlier this year that Europe is the fastest growing geographic region for its eClinical technology products.

BioClinica, a Gold Certified member of Microsoft's Partner Network, held the inaugural event at the Microsoft Executive Briefing Center in Cologne on February 26. Several industry-leading pharmaceutical companies including Johnson & Johnson, Nestlé, Grünenthal, Sanofi, Biosense Webster and TauRx led presentations and case studies.

BioClinica’s Peter Benton, President eClinical Solutions, said, “Our customers are our best advocates and the success stories they shared illustrate the strength of BioClinica’s solutions. We appreciate the high level of participation and regard it as yet another sign of increasing demand for our product.” BioClinica currently supports its European customer base from offices in Lyon, France; Leiden, the Netherlands; and Munich, Germany, with additional personnel in Switzerland, Belgium, the United Kingdom, and across Germany.

Conference attendees watched demonstrations of next generation innovations in breakout sessions aligned by product. The OnPoint CTMS track was especially popular, underscoring BioClinica’s best-selling product in Europe. Nestlé, Sanofi, and Biosense Webster led CTMS sessions on topics including successful implementation, integration, and risk-based monitoring while Johnson & Johnson presented a strong case study on supplies planning utilizing BioClinica’s Optimizer predictive forecasting technology.

According to Martijn Princen, BioClinica's Head of European eClinical Sales, “This was a valuable experience both for customers as well as our software development team, who are continually making product enhancements to meet future needs.” “He added, “We look forward to hosting a European User Conference again next year.”

BioClinica will hold its Global User Conference on May 5-7 in Philadelphia, Pennsylvania.

Follow BioClinica on the Trial Blazers blog at www.bioclinica.com/blog and on twitter at http://twitter.com/bioclinica. More information on BioClinica's European user conference can be found at http://www.bioclinica.com/news-events/events/bioclinica-european-user-conference.

About BioClinica, Inc.

BioClinica, Inc. is a leading global provider of integrated clinical trial management technologies including eClinical solutions for electronic data capture (EDC), randomization (IRT), clinical trial management (CTMS), and clinical trial supply management, forecasting and optimization (CTSM). BioClinica’s Imaging and Cardiovascular division offers unmatched scientific expertise with its team of respected medical researchers; electronic transfer, management, and independent review of medical images; plus cardiovascular safety monitoring including automated ECG, Thorough QT studies, Holter monitoring, ambulatory blood pressure monitoring and pulse wave analysis. With more than 29 years of experience and over 3000 successful trials to date, BioClinica has supported the development of many new medicines through all phases of the clinical trial process. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on three continents, and supports worldwide eClinical, comprehensive cardiovascular safety, and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES